Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03721809Completed
Trial (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Quantitative measurement of plasma IL-1β at Day 1. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03721809.